Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.63, $0.19 better than the analyst estimate of $0.44. Revenue for the quarter came in at $232.7 million versus the consensus estimate of $216.88 million.

GUIDANCE:

Conmed sees FY2021 EPS of $3.05-$3.20, versus the consensus of $2.94.

For earnings history and earnings-related data on Conmed (CNMD) click here.